Dynamic Purchasing System for Pharmaceutical Products
Originaltitel der Bekanntmachung
Italy – Pharmaceutical products – Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici. Finalizzato alla partecipazione di Appalti specifici per la stipula di Convenzioni/Accordi quadro. Il SDA potrà.
Opportunity Score
Warum diese Bewertung?
Chance
60 / 100
Komplexität
40 / 100
Risikofaktoren
Structured data indicates DPS duration of 132 months and EU-funded, but XML notice shows 96 months validity and no EU f...
No procurement documents were analyzed; eligibility, award criteria, and detailed requirements are unknown.
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Eckdaten der Ausschreibung
- Öffentlicher Auftraggeber
- Intercent-ER — Agenzia regionale per lo sviluppo dei mercati telematici
- Land
- Italien
- CPV
- 33600000 - Pharmaceutical products
- Frist
- Feb 24, 2028
- Geschätzter Wert
- EUR 15000M
Überblick
Moderate opportunityWichtige Fakten
- EUR 15000M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 132 MONTH
- Establishment of a Dynamic Purchasing System for pharmaceutical products
- Specific contracts to be awarded via invitation to qualified suppliers
Vollständige Zusammenfassung anzeigen
Establishment of a Dynamic Purchasing System (DPS) for pharmaceutical products, usable by Intercent-ER and regional health authorities. Single lot (LOT-0000) with estimated value of €15 billion. The DPS has a duration of 132 months (per structured data) but XML notice indicates 96 months validity. Submission deadline is 2028-02-24. Inconsistencies exist in duration and EU funding flags. Procedure is restricted; language is Italian only.
Risiken
Structured data indicates DPS duration of 132 months and EU-funded, but XML notice shows 96 months validity and no EU f...
No procurement documents were analyzed; eligibility, award criteria, and detailed requirements are unknown.
Restricted procedure — pre-qualification required
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Admission to DPS via electronic request throughout its validity
- Compliance with requirements specified in individual invitations
Administrative
- Electronic submission only via the provided platform
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
Bologna, ITA
Auftraggeberprofil
Kennung
0000246017
Tätigkeit
General public services
Lose (1)
LOT-0000
Dynamic Purchasing System for Pharmaceutical Products
Establishment of a DPS for the supply of pharmaceutical products. Specific contracts will be awarded via invitations, with detailed requirements per contract.
EUR 15B
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Le prestazioni oggetto degli appalti specifici ed i requisiti di conformità, compatibilità, e le caratteristiche minime saranno dettagliati nelle singole lettere di invito e nella documentazione ad esse allegata.
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
Istituzione del Sistema Dinamico di Acquisizione per la fornitura di Beni Farmaceutici. Finalizzato alla partecipazione di Appalti specifici per la stipula di Convenzioni/Accordi quadro. Il SDA potrà.
Originale TED-Beschreibung
Le prestazioni oggetto degli appalti specifici ed i requisiti di conformità, compatibilità, e le caratteristiche minime saranno dettagliati nelle singole lettere di invito e nella documentazione ad esse allegata.
Vergabedetails
- Veröffentlichungsdatum
- 24 Feb 2025
- Sprachen
- Italian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 125860-2025
Dokumente (2)
Ähnliche Ausschreibungen
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Warum diese Bewertung?
Chance
60 / 100
Komplexität
40 / 100
Risikofaktoren
Structured data indicates DPS duration of 132 months and EU-funded, but XML notice shows 96 months validity and no EU f...
No procurement documents were analyzed; eligibility, award criteria, and detailed requirements are unknown.
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications